PMA submission targeted for Q1 2026 following positive Tigris results and ongoing FDA interactionsCompany to host Corporate Update call on Wednesday, December 10, 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback